Creighton Model FertilityCare System is a standardized modification of Billings Ovulation Method.
Research leading to the development of the Creighton Model System began in 1976 and the system was first fully described in 1980. The research on this system has continued up until the present day and it has an extraordinary degree of scientific understanding and validity.
The CREIGHTON MODEL FertilityCare™ System relies upon the standardized observation and charting of biological markers that are essential to a woman's health and fertility. These “biomarkers” give the couple a thorough knowledge and understanding of their naturally-occurring phases of fertility and infertility. Through this understanding, the couple is able to make decisions (choices) regarding the achievement or avoidance of pregnancy.
In addition, it provides women the added benefit of being able to monitor and maintain their procreative and gynaecologic health over a lifetime. It is truly the only family planning system which has networked family planning with gynaecologic and procreative healthcare. Because the CREIGHTON MODEL FertilityCare™ System is based upon various biological markers, it can be used as a means of monitoring and maintaining reproductive and gynaecologic health. Investigation of this has given birth to the new women’s health science of NaProTECHNOLOGY. After many years of extensive evaluation, these biomarkers have been shown to reveal the presence or absence of certain types of pathologic or physiologic abnormalities. They allow the physician to treat abnormalities of the menstrual cycle in cooperation with its function.
More to follow...
